Skip to main content
Clinical Trials/ACTRN12619000339156
ACTRN12619000339156
Completed
未知

A prospective, randomised non-blinded pilot study to optimise oral tranexamic acid dosing in primary total knee arthroplasty

Wesley Medical Research0 sites35 target enrollmentMarch 5, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
osteoarthritis
Sponsor
Wesley Medical Research
Enrollment
35
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 5, 2019
End Date
November 20, 2019
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • participants of either sex scheduled to undergo a primary, unilateral TKA (either anterior or posterior approach, but not joint resurfacing)
  • \- available for follow up at 6 months post\-surgery
  • \- willingness to provide written, informed consent
  • \- willingness to comply with the study

Exclusion Criteria

  • \- known allergy to TXA
  • \- acquired disturbances to colour vision
  • \- preoperative use of anticoagulants (within 5 days of surgery)
  • \- fibrinolytic disorders requiring intraoperative fibrinolytics
  • \- coagulopathy, history of arteriolar or venous thromboembolic disease
  • \- pregnancy or breastfeeding
  • \- hepatic failure
  • \- haemoglobin \<10g/dL

Outcomes

Primary Outcomes

Not specified

Similar Trials